Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
HealthEquity management to meet virtually with KeyBanc » 06:57
06/24/21
06/24
06:57
06/24/21
06:57
HQY

HealthEquity

$83.72 /

+1.43 (+1.74%)

Virtual Meeting to be…

Virtual Meeting to be held on June 29 hosted by KeyBanc.

ShowHide Related Items >><<
HQY HealthEquity
$83.72 /

+1.43 (+1.74%)

HQY HealthEquity
$83.72 /

+1.43 (+1.74%)

06/10/21 Raymond James
HealthEquity price target raised to $90 from $85 at Raymond James
06/08/21 Cantor Fitzgerald
HealthEquity price target raised to $85 from $82 at Cantor Fitzgerald
04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
HQY HealthEquity
$83.72 /

+1.43 (+1.74%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$83.72 /

+1.43 (+1.74%)

Over a week ago
Conference/Events
HealthEquity management to meet virtually with Oppenheimer » 11:47
06/11/21
06/11
11:47
06/11/21
11:47
HQY

HealthEquity

$78.38 /

+0.4 (+0.51%)

Virtual Meeting to be…

Virtual Meeting to be held on June 11 hosted by Oppenheimer.

ShowHide Related Items >><<
HQY HealthEquity
$78.38 /

+0.4 (+0.51%)

HQY HealthEquity
$78.38 /

+0.4 (+0.51%)

06/10/21 Raymond James
HealthEquity price target raised to $90 from $85 at Raymond James
06/08/21 Cantor Fitzgerald
HealthEquity price target raised to $85 from $82 at Cantor Fitzgerald
04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
HQY HealthEquity
$78.38 /

+0.4 (+0.51%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$78.38 /

+0.4 (+0.51%)

Recommendations
HealthEquity price target raised to $90 from $85 at Raymond James » 07:51
06/10/21
06/10
07:51
06/10/21
07:51
HQY

HealthEquity

$78.00 /

-3.56 (-4.36%)

Raymond James analyst C.…

Raymond James analyst C. Gregory Peters raised the firm's price target on HealthEquity to $90 from $85 and keeps a Strong Buy rating on the shares. The stock has traded down ~5% since reporting Q1 results due in part to reporting lower than expected service revenue as the company's commuter business continues to be impacted by COVID restrictions and the WFM environment, Peters tells investors in a research note.

ShowHide Related Items >><<
HQY HealthEquity
$78.00 /

-3.56 (-4.36%)

HQY HealthEquity
$78.00 /

-3.56 (-4.36%)

06/08/21 Cantor Fitzgerald
HealthEquity price target raised to $85 from $82 at Cantor Fitzgerald
04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
HQY HealthEquity
$78.00 /

-3.56 (-4.36%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$78.00 /

-3.56 (-4.36%)

Hot Stocks
HealthEquity updates business outlook to exclude Further acquisition expenses » 09:17
06/08/21
06/08
09:17
06/08/21
09:17
HQY

HealthEquity

$82.31 /

+1.16 (+1.43%)

HealthEquity announced an…

HealthEquity announced an updated business outlook, superseding the business outlook announced by HealthEquity on June 7. The updated business outlook is being issued to exclude anticipated merger integration expenses related to the Further acquisition that were included in the previously announced business outlook. Updated business outlook: For FY22, management expects revenues of $755M-$765M. Its outlook for net loss is between $12M-$8M up from net loss of $19M-$15M, resulting in net loss of 14c-10c per diluted share, up from net loss of 23c-18c per diluted share. Its outlook for non-GAAP net income is between $122M-$126M, resulting in non-GAAP net income per diluted share of $1.45-$1.50. Management expects Adjusted EBITDA of $241M-$247M. This outlook does not include any potential impact from the acquisitions of Further or the Fifth Third Bank HSA portfolio.

ShowHide Related Items >><<
HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

06/08/21 Cantor Fitzgerald
HealthEquity price target raised to $85 from $82 at Cantor Fitzgerald
04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

Recommendations
HealthEquity price target raised to $85 from $82 at Cantor Fitzgerald » 07:07
06/08/21
06/08
07:07
06/08/21
07:07
HQY

HealthEquity

$82.31 /

+1.16 (+1.43%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Steven Halper raised the firm's price target on HealthEquity to $85 from $82 and keeps an Overweight rating on the shares following the company's Q1 results. In FY22, the company continues to face headwinds from COVID, including sales deferrals for its HSA/CDB platform as well as continued lower revenue from commuter programs, but Halper tells investors in a research note that these headwinds are likely to ease later this year as the economy reopens. The analyst is confident company's ability to return to double-digit revenue growth in FY23 and beyond.

ShowHide Related Items >><<
HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

On The Fly
Fly Intel: After-Hours Movers » 18:31
06/07/21
06/07
18:31
06/07/21
18:31
SFIX

Stitch Fix

$58.21 /

+2.74 (+4.94%)

, REVG

REV Group

$19.63 /

+0.345 (+1.79%)

, MRVL

Marvell

$48.30 /

-0.42 (-0.86%)

, CYCN

Cyclerion Therapeutics

$3.13 /

-0.06 (-1.88%)

, SLQT

SelectQuote

$19.55 /

-0.24 (-1.21%)

, CHS

Chico's

$5.75 /

+0.37 (+6.88%)

, COUP

Coupa Software

$236.34 /

+6.33 (+2.75%)

, HQY

HealthEquity

$82.31 /

+1.16 (+1.43%)

, PLBY

PLBY Group

$52.23 /

+6.38 (+13.91%)

, APR

Apria

$31.01 /

+0.235 (+0.76%)

, LESL

Leslie's

$31.22 /

+1.52 (+5.12%)

, MARA

Marathon Digital

$24.36 /

+0.03 (+0.12%)

, KDP

Keurig Dr Pepper

$36.85 /

-0.04 (-0.11%)

, RIOT

Riot Blockchain

$28.82 /

-0.33 (-1.13%)

, ETSY

Etsy

$168.33 /

+4.13 (+2.52%)

Check out this evening's…

ShowHide Related Items >><<
SLQT SelectQuote
$19.55 /

-0.24 (-1.21%)

SFIX Stitch Fix
$58.21 /

+2.74 (+4.94%)

RIOT Riot Blockchain
$28.82 /

-0.33 (-1.13%)

REVG REV Group
$19.63 /

+0.345 (+1.79%)

PLBY PLBY Group
$52.23 /

+6.38 (+13.91%)

MRVL Marvell
$48.30 /

-0.42 (-0.86%)

MARA Marathon Digital
$24.36 /

+0.03 (+0.12%)

LESL Leslie's
$31.22 /

+1.52 (+5.12%)

KDP Keurig Dr Pepper
$36.85 /

-0.04 (-0.11%)

HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

ETSY Etsy
$168.33 /

+4.13 (+2.52%)

CYCN Cyclerion Therapeutics
$3.13 /

-0.06 (-1.88%)

COUP Coupa Software
$236.34 /

+6.33 (+2.75%)

CHS Chico's
$5.75 /

+0.37 (+6.88%)

APR Apria
$31.01 /

+0.235 (+0.76%)

SFIX Stitch Fix
$58.21 /

+2.74 (+4.94%)

06/08/21 MKM Partners
Stitch Fix price target raised to $45 from $29 at MKM Partners
06/08/21 Wells Fargo
Stitch Fix price target raised to $35 from $27 at Wells Fargo
06/08/21 Morgan Stanley
Stitch Fix report had 'something for bulls and bears,' says Morgan Stanley
06/08/21 Baird
Stitch Fix price target raised to $70 from $60 at Baird
REVG REV Group
$19.63 /

+0.345 (+1.79%)

06/08/21 Baird
REV Group demand and operating momentum still building, says Baird
03/12/21 BMO Capital
REV Group price target raised to $19 from $10 at BMO Capital
03/11/21 Morgan Stanley
REV Group price target raised to $18 from $10 at Morgan Stanley
03/10/21 Baird
REV Group price target raised to $22 from $20 at Baird
MRVL Marvell
$48.30 /

-0.42 (-0.86%)

06/08/21 Craig-Hallum
Marvell price target raised to $63 from $52 at Craig-Hallum
06/08/21 Rosenblatt
Marvell price target raised to $70 from $60 at Rosenblatt
06/08/21 KeyBanc
Marvell price target raised to $60 from $55 at KeyBanc
06/08/21 Evercore ISI
Marvell price target raised to $63 from $55 at Evercore ISI
CYCN Cyclerion Therapeutics
$3.13 /

-0.06 (-1.88%)

SLQT SelectQuote
$19.55 /

-0.24 (-1.21%)

05/21/21 Piper Sandler
SelectQuote recent weakness a buying opportunity, says Piper Sandler
05/13/21 Truist
GoHealth price target lowered to $20 from $26 at Truist
05/12/21 Piper Sandler
SelectQuote should be bought on any guidance selloff, says Piper Sandler
04/06/21 Piper Sandler
SelectQuote assumed with an Overweight at Piper Sandler
CHS Chico's
$5.75 /

+0.37 (+6.88%)

03/03/21 B. Riley
Chico's price target raised to $2.50 from $2 at B. Riley Securities
01/15/21 B. Riley
Chico's price target raised to $2 from $1.50 at B. Riley Securities
11/17/20 B. Riley
Chico's downgraded to Neutral on delayed recovery at B. Riley Securities
11/17/20 B. Riley
Chico's downgraded to Neutral from Buy at B. Riley Securities
COUP Coupa Software
$236.34 /

+6.33 (+2.75%)

06/08/21 Needham
Coupa Software price target lowered to $280 from $385 at Needham
06/08/21 Truist
Coupa Software price target lowered to $326 from $386 at Truist
06/08/21 KeyBanc
Coupa Software price target lowered to $350 from $400 at KeyBanc
06/08/21 Raymond James
Coupa Software price target lowered to $300 from $365 at Raymond James
HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

06/08/21 Cantor Fitzgerald
HealthEquity price target raised to $85 from $82 at Cantor Fitzgerald
04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
PLBY PLBY Group
$52.23 /

+6.38 (+13.91%)

05/13/21 Craig-Hallum
PLBY Group price target raised to $50 from $35 at Craig-Hallum
05/13/21 Canaccord
PLBY Group price target raised to $52 from $28 at Canaccord
04/07/21 Roth Capital
PLBY Group price target raised to $35 from $26 at Roth Capital
04/06/21 Canaccord
Canaccord sees Nifty Gateway partnership as initial step in PLBY's NFT strategy
APR Apria
$31.01 /

+0.235 (+0.76%)

05/17/21 Citi
Apria resumed with a Buy at Citi
04/15/21 Piper Sandler
Apria price target raised to $33 from $29 at Piper Sandler
03/31/21 Citi
Apria price target raised to $30 from $26 at Citi
03/31/21 Piper Sandler
Apria price target raised to $29 from $27 at Piper Sandler
LESL Leslie's
$31.22 /

+1.52 (+5.12%)

06/04/21 Loop Capital
Pool Corp. price target raised to $470 from $440 at Loop Capital
06/04/21 Loop Capital
Leslie's price target raised to $33 from $31 at Loop Capital
05/06/21 Loop Capital
Leslie's price target raised to $31 from $28 at Loop Capital
05/06/21 Baird
Leslie's price target raised to $35 from $33 at Baird
MARA Marathon Digital
$24.36 /

+0.03 (+0.12%)

05/26/21
Fly Intel: Top five analyst initiations
05/26/21 B. Riley
Marathon Digital initiated with a Buy, $47 target at B. Riley
05/25/21 B. Riley
Marathon Digital initiated with a Buy at B. Riley
03/17/21 H.C. Wainwright
Marathon Digital price target raised to $50 from $30 at H.C. Wainwright
KDP Keurig Dr Pepper
$36.85 /

-0.04 (-0.11%)

03/19/21
Fly Intel: Top five analyst upgrades
03/19/21 JPMorgan
Keurig Dr Pepper upgraded to Overweight from Neutral at JPMorgan
03/11/21 Morgan Stanley
Morgan Stanley downgrades Keurig Dr Pepper to Equal Weight after outperformance
03/11/21 Morgan Stanley
Keurig Dr Pepper downgraded to Equal Weight from Overweight at Morgan Stanley
RIOT Riot Blockchain
$28.82 /

-0.33 (-1.13%)

06/01/21 B. Riley
Riot Blockchain deal closing 'major positive' for shares, says B. Riley
06/01/21 H.C. Wainwright
Riot Blockchain price target raised to $40 from $30 at H.C. Wainwright
05/26/21 B. Riley
Riot Blockchain initiated with a Buy, $43 target at B. Riley
ETSY Etsy
$168.33 /

+4.13 (+2.52%)

06/07/21
Fly Intel: Top five analyst initiations
06/07/21 Atlantic Equities
Etsy initiated with an Overweight, $200 target at Atlantic Equities
06/07/21 Atlantic Equities
Etsy initiated with an Overweight at Atlantic Equities
06/03/21 Roth Capital
Depop acquisition deepens Etsy apparel/youth cohort expansion, says Roth Capital
SLQT SelectQuote
$19.55 /

-0.24 (-1.21%)

SFIX Stitch Fix
$58.21 /

+2.74 (+4.94%)

RIOT Riot Blockchain
$28.82 /

-0.33 (-1.13%)

REVG REV Group
$19.63 /

+0.345 (+1.79%)

PLBY PLBY Group
$52.23 /

+6.38 (+13.91%)

MRVL Marvell
$48.30 /

-0.42 (-0.86%)

MARA Marathon Digital
$24.36 /

+0.03 (+0.12%)

LESL Leslie's
$31.22 /

+1.52 (+5.12%)

KDP Keurig Dr Pepper
$36.85 /

-0.04 (-0.11%)

HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

ETSY Etsy
$168.33 /

+4.13 (+2.52%)

COUP Coupa Software
$236.34 /

+6.33 (+2.75%)

CHS Chico's
$5.75 /

+0.37 (+6.88%)

APR Apria
$31.01 /

+0.235 (+0.76%)

  • 10
    Jun
  • 10
    Jun
  • 08
    Jun
  • 10
    Jun
  • 17
    Mar
  • 04
    Mar
  • 17
    Feb
  • 11
    Feb
  • 11
    Feb
  • 17
    Nov
  • 03
    Nov
  • 29
    Oct
  • 18
    Aug
  • 03
    Aug
  • 24
    Jul
  • 09
    Jul
SFIX Stitch Fix
$58.21 /

+2.74 (+4.94%)

RIOT Riot Blockchain
$28.82 /

-0.33 (-1.13%)

PLBY PLBY Group
$52.23 /

+6.38 (+13.91%)

MRVL Marvell
$48.30 /

-0.42 (-0.86%)

ETSY Etsy
$168.33 /

+4.13 (+2.52%)

SLQT SelectQuote
$19.55 /

-0.24 (-1.21%)

SFIX Stitch Fix
$58.21 /

+2.74 (+4.94%)

RIOT Riot Blockchain
$28.82 /

-0.33 (-1.13%)

REVG REV Group
$19.63 /

+0.345 (+1.79%)

PLBY PLBY Group
$52.23 /

+6.38 (+13.91%)

MRVL Marvell
$48.30 /

-0.42 (-0.86%)

MARA Marathon Digital
$24.36 /

+0.03 (+0.12%)

LESL Leslie's
$31.22 /

+1.52 (+5.12%)

KDP Keurig Dr Pepper
$36.85 /

-0.04 (-0.11%)

HQY HealthEquity
$82.31 /

+1.16 (+1.43%)

ETSY Etsy
$168.33 /

+4.13 (+2.52%)

COUP Coupa Software
$236.34 /

+6.33 (+2.75%)

APR Apria
$31.01 /

+0.235 (+0.76%)

SLQT SelectQuote
$19.55 /

-0.24 (-1.21%)

SFIX Stitch Fix
$58.21 /

+2.74 (+4.94%)

RIOT Riot Blockchain
$28.82 /

-0.33 (-1.13%)

PLBY PLBY Group
$52.23 /

+6.38 (+13.91%)

MRVL Marvell
$48.30 /

-0.42 (-0.86%)

MARA Marathon Digital
$24.36 /

+0.03 (+0.12%)

LESL Leslie's
$31.22 /

+1.52 (+5.12%)

ETSY Etsy
$168.33 /

+4.13 (+2.52%)

COUP Coupa Software
$236.34 /

+6.33 (+2.75%)

Earnings
HealthEquity raises FY22 EPS view to $1.45-$1.50 from $1.37-$1.42 » 16:10
06/07/21
06/07
16:10
06/07/21
16:10
HQY

HealthEquity

$82.15 /

+1 (+1.23%)

Consensus $1.41. Raises…

Consensus $1.41. Raises FY22 revenue view to $755M-$765M from $750M-$760M, consensus $755.51M. The company said, "For the fiscal year ending January 31, 2022, management expects revenues of $755 million to $765 million. Its outlook for net loss is between $19 million and $15 million, resulting in net loss of $0.23 to $0.18 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $122 million and $126 million, resulting in non-GAAP net income per diluted share of $1.45 to $1.50 (based on an estimated 84 million diluted weighted-average shares outstanding). Management expects Adjusted EBITDA of $241 million to $247 million."

ShowHide Related Items >><<
HQY HealthEquity
$82.15 /

+1 (+1.23%)

HQY HealthEquity
$82.15 /

+1 (+1.23%)

04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
HQY HealthEquity
$82.15 /

+1 (+1.23%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$82.15 /

+1 (+1.23%)

Earnings
HealthEquity reports Q1 EPS 38c, consensus 32c » 16:06
06/07/21
06/07
16:06
06/07/21
16:06
HQY

HealthEquity

$81.61 /

+0.46 (+0.57%)

Reports Q1 revenue…

Reports Q1 revenue $184.2M, consensus $180.34M. "Our fiscal year 2022 is off to a fast start with early sales wins, two material acquisition agreements in our core HSA business, and the new Luum mobility benefits platform helping clients return to work," said Jon Kessler, President and CEO of HealthEquity. "We believe our total solution is well-positioned to deliver substantial growth through the economy's reopening and recovery."

ShowHide Related Items >><<
HQY HealthEquity
$81.61 /

+0.46 (+0.57%)

HQY HealthEquity
$81.61 /

+0.46 (+0.57%)

04/29/21 JPMorgan
HealthEquity resumed with an Overweight at JPMorgan
03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
HQY HealthEquity
$81.61 /

+0.46 (+0.57%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$81.61 /

+0.46 (+0.57%)

Over a month ago
Initiation
HealthEquity resumed with an Overweight at JPMorgan » 07:21
04/29/21
04/29
07:21
04/29/21
07:21
HQY

HealthEquity

$76.43 /

+0.2 (+0.26%)

JPMorgan analyst Anne…

JPMorgan analyst Anne Samuel resumed coverage of HealthEquity with an Overweight rating and $82 price target. The analyst recommends names in the Healthcare IT space that are "well positioned around the shift to the consumer with fundamental market drivers and differentiated offerings," while positioning away from the electronic medical record space "which faces market maturation." Phreesia (PHR) and Progyny (PGNY) are her favorite ways to play the space.

ShowHide Related Items >><<
HQY HealthEquity
$76.43 /

+0.2 (+0.26%)

HQY HealthEquity
$76.43 /

+0.2 (+0.26%)

03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
02/09/21 Barrington
HealthEquity price target raised to $90 from $75 at Barrington
HQY HealthEquity
$76.43 /

+0.2 (+0.26%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$76.43 /

+0.2 (+0.26%)

Conference/Events
HealthEquity management to meet virtually with Truist » 04:55
04/23/21
04/23
04:55
04/23/21
04:55
HQY

HealthEquity

$73.47 /

+2.27 (+3.19%)

Virtual Meeting to be…

Virtual Meeting to be held on April 21 hosted by Truist.

ShowHide Related Items >><<
HQY HealthEquity
$73.47 /

+2.27 (+3.19%)

HQY HealthEquity
$73.47 /

+2.27 (+3.19%)

03/22/21 Raymond James
HealthEquity price target lowered to $85 from $100 at Raymond James
03/17/21 Deutsche Bank
HealthEquity price target raised to $92 from $88 at Deutsche Bank
02/10/21 Raymond James
HealthEquity price target raised to $100 from $75 at Raymond James
02/09/21 Barrington
HealthEquity price target raised to $90 from $75 at Barrington
HQY HealthEquity
$73.47 /

+2.27 (+3.19%)

  • 17
    Mar
  • 17
    Feb
  • 09
    Jul
HQY HealthEquity
$73.47 /

+2.27 (+3.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.